The FDA assigned a PDUFA target action date of December 22, 2026 – – The NDA is based on positive data from a successful clinical program demonstrating favorable safety and blood pressure reduction in ...

A nerve stimulator implant called Inspire is helping some sleep apnea patients breathe normally at night when a CPAP machine is not an effective treatment.

Announced at HIMSS26, the companies will deliver a bundled solution that unlocks advanced insights for study sponsorsDALLAS--(BUSINESS WIRE)--Verily Life Sciences and Samsung Electronics America today ...

Amazon Pharmacy expands Zepbound access by offering Eli Lilly’s KwikPen for home delivery, including same-day service in nearly 3,000 cities.

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), ...

Medically reviewed by Daniel Combs, MD Key Takeaways In OSA, the complex interplay between intermittent oxygen deprivation, ...

GLP-1 therapies are transforming obesity treatment by targeting appetite regulation and metabolic health. Experts explain how these medications support long-term weight management ...

Frequent late-night hunger may reflect hormonal shifts, sleep disruption or metabolic conditions rather than poor ...

At 2a.m. local time on Sunday, March 8, 2026, clocks jump forward one hour, known as Daylight Saving Time. While this means we will lose an hour of sleep, we gain more evening daylight. One expert ...

Shareholders of Inspire Medical Systems would probably like to forget the past six months even happened. The stock dropped 22 ...